The RGH (Repatriation General
Hospital) Pharmacy E-Bulletin this
week zeroes in on the management
of cardiovascular disease (CVD)
associated with diabetes type 2.
The bulletin concludes that “a
continuing focus on cardiovascular
outcomes will be required to
elucidate the nature of safety issues
associated with the drugs used to
manage this very common illness.”
CLICK HERE to access the bulletin.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Dec 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.